Kim Newton - Genentech USA

Kim Newton - Genentech USA

Davis Auditorium
Start Time: 
Mon, 28/11/2022 - 1:00pm
End Time: 
Mon, 28/11/2022 - 2:00pm

WEHI Special Seminar hosted by Professor Andreas Strasser

Kim Newton

Senior Principal Scientist, Physiological Chemistry, Genentech

Targeted alveolar regeneration with Frizzled-specific agonists


Davis Auditorium

Online access via Slido
and enter code WEHIseminar

Including Q&A session


I joined Genentech in 2001 as a postdoc after completing my PhD in the cell death lab of Andreas Strasser at the Walter & Eliza Hall Institute in Australia. As a postdoc with Vishva Dixit, I worked on several projects including the role of the adaptor protein CARMA1/CARD11 in lymphocyte development and activation, the effect of TNF family ligands EDA-A1 and EDA-A2 on hair, sweat gland and muscle homeostasis, and the characterization of a kinase called RIPK3, which turned out to be a key effector of a regulated form of necrotic cell death termed necroptosis. These diverse projects were developed in collaboration with several departments and I saw first hand how much can be achieved when experts across disciplines pull together. Enthusiastic, talented colleagues combined with exciting, medically relevant science made staying on as a scientist an easy decision.

The current mission of my group is to decipher the signaling mechanisms unleashing proinflammatory cell death programs that may exacerbate a range of inflammatory diseases. Our goal is to unveil novel therapeutics targets with the potential to benefit patients.

All welcome!